81. Metabolomic Approaches to TB Drug Development: Looking Downstream of DNA
Session: Symposium: Systems Biology Approaches to Infectious Diseases
Thursday, October 20, 2011: 3:45 PM
Room: 104ABC


Kyu Rhee, MD, PhD, Weill Cornell Medical College, New York, NY

Dr. Rhee is an Associate Professor of Medicine and of Microbiology & Immunology at Weill Cornell Medical College. He received graduate training at the University of California, Irvine through a medical scientist training program and clinical training in Internal Medicine and Infectious Diseases at Weill Cornell where he is currently the William Randolph Hearst Clinical Scholar in Microbiology & Infectious Diseases. Research in his laboratory centers around chemical-biologic studies of antibiotic action and resistance, with a particular focus on the clinically significant pathogens Mycobacterium tuberculosis and Staphylococcus aureus. Work over the past several years has concentrated specifically on the development and application of novel, mass spectrometry-based metabolomic studies of microbial physiology and antibiotic activity.



Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.